2024-09-11 - Analysis Report
## CVS Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and healthcare services. 

**1. Performance vs. S&P 500:**

* **Cumulative Return:** CVS has experienced a cumulative return of -21.51% compared to the S&P 500 (VOO) which has a cumulative return of 83.37%.
* **Relative Performance:** The current relative performance of CVS is -104.88, which means it's lagging behind the S&P 500 by a significant margin. This indicates that CVS has underperformed significantly compared to the broader market. 

**2. Recent Price Movement:**

* **Closing Price:** $56.47
* **5-Day Moving Average:** $57.79 
* **20-Day Moving Average:** $57.63 
* **60-Day Moving Average:** $58.72

The stock price is currently below all three moving averages, suggesting a possible downward trend in the short term.

**3. Technical Indicators:**

* **RSI:** 37.35 - The RSI is below 50, indicating that the stock is currently oversold.
* **PPO:** -0.03 - The PPO is negative, suggesting a potential downtrend.
* **Delta_Previous_Relative_Divergence:** -3.58 - This negative value indicates a potential short-term downtrend. 
* **Expected Return:** 12.01% - This is a 5-year expected return estimate based on current investment.

The combination of technical indicators suggests a potential downward trend, however, the expected return indicates potential for growth in the long term.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings for the quarter ending August 7th, 2024, were $1.83, exceeding the expected EPS of $1.73. This suggests positive momentum in recent performance.

**5. Overall Analysis:**

CVS has underperformed the S&P 500 significantly in the past, showing a large negative relative performance. Recent price movement indicates a possible short-term downtrend, supported by technical indicators like RSI and PPO. However, the expected return indicates potential long-term growth. Recent earnings have exceeded expectations, showing positive momentum. 

**6. Conclusion:**

CVS's performance against the S&P 500 and technical indicators suggest a potential short-term downtrend. However, its recent earnings performance and positive expected return may offer potential for long-term growth. Investors should consider these factors before making any investment decisions. 
